EMA opens review of China's Sinovac coronavirus jab

The Hague (AFP) May 4, 2021

Europe's medicines watchdog said Tuesday it has started reviewing China's Sinovac coronavirus jab, a process that could lead to eventual approval for the European market. Made by Sinovac's Beijing-based Life Sciences unit, the vaccine by the Chinese biotech firm is the second shot developed outside the West after Russia's Sputnik V to be considered for European use by the European Medicines